Back
SpringWorks Therapeutics Stock Price Chart
Sponsored
SWTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
SWTX
SpringWorks Therapeutics
Last Price:
39.03
Seasonality Move:
51.03%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.62 | Buy |
20-day SMA: | 33.67 | Buy |
50-day SMA: | 32.73 | Buy |
200-day SMA: | 40 | Sell |
8-day EMA: | 36.55 | Buy |
20-day EMA: | 34.6 | Buy |
50-day EMA: | 34.01 | Buy |
200-day EMA: | 36.31 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 67.93 | Buy |
Chaikin Money Flow: | 918266 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SpringWorks Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 39.02 while SWTX 8-day simple moving average is 36.62, which is a Buy signal.
- The stock price of SWTX is 39.02 while SpringWorks Therapeutics 20-day SMA is 33.67, which makes it a Buy.
- SpringWorks Therapeutics 50-day simple moving average is 32.73 while SWTX share price is 39.02, making it a Buy technically.
- SWTX stock price is 39.02 and SpringWorks Therapeutics 200-day simple moving average is 40.00, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Buy
55
SpringWorks Therapeutics (SWTX)
is a Buy
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a Buy
The current SpringWorks Therapeutics [SWTX] share price is $39.02. The Score for SWTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
39.02
Share Volume:
1.41M
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
20.19
Buy
55
SpringWorks Therapeutics (SWTX)
is a Buy
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?
The SpringWorks Therapeutics stock price is 39.02 USD today. -
Will SWTX stock go up or go down?
SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is SpringWorks Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is not overvalued.
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 39.02 while SWTX 8-day exponential moving average is 36.55, which is a Buy signal.
- The stock price of SWTX is 39.02 while SpringWorks Therapeutics 20-day EMA is 34.60, which makes it a Buy.
- SpringWorks Therapeutics 50-day exponential moving average is 34.01 while SWTX share price is 39.02, making it a Buy technically.
- SWTX stock price is 39.02 and SpringWorks Therapeutics 200-day simple moving average is 36.31, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.22 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
- SWTX Moving Average Covergence Divergence (MACD) indicator is 1.55, suggesting SpringWorks Therapeutics is a Buy
- SpringWorks Therapeutics Relative Strength Index (RSI) is 67.93, which suggest SpringWorks Therapeutics is overbought
- The Bollinger Bands (25) for SpringWorks Therapeutics is ( - ), which suggest SpringWorks Therapeutics is a Buy
- The Bollinger Bands (100) for SpringWorks Therapeutics is ( - ), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.